Tadros, JosephRahnama-Moghadam, Sahand2019-06-182019-06-182018-10-15Tadros, J., & Rahnama-Moghadam, S. (2018). Erythema annulare centrifugum-type eruption in a patient undergoing cancer vaccine immunotherapy. Dermatology Online Journal, 24(10).1087-2108https://hdl.handle.net/1805/19629Sipuleucel-T is a cellular immunotherapy approved for the treatment of metastatic castration-resistant prostate cancer. We report a patient developing an immune related adverse effect from sipuleucel-T drug-induced erythema annulare centrifugum-like eruption. A brief review of the mechanism and implications of this eruption are also included.en-USAttribution-NonCommercial-NoDerivs 3.0 United Statesimmunotherapyimmune related adverse eventserythema annulare centrifugumSipuleucel-TArticle